BioMarin Pharmaceutical's total assets for Q2 2026 were $11.72B, an increase of 36.46% from the previous quarter. MX:BMRN total liabilities were $5.40B for the fiscal quarter, a 127.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.